
A flexible population-based prescription opioid registry was established for addressing a broad range of critical public health questions relating to prescription opioid use.
A flexible population-based prescription opioid registry was established for addressing a broad range of critical public health questions relating to prescription opioid use.
A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Published: May 17th 2016 | Updated:
Published: May 16th 2017 | Updated:
Published: July 1st 2000 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.